Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$448,393
-$73,726 QoQ
Shares Held
18,621
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#1,836
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $10,204,212 across 14 Drug Manufacturers - General names. PFE ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,220 | $3,326,680 | |
| 2 | JNJ |
Johnson & Johnson
|
8,020 | $2,036,839 | |
| 3 | AMGN |
Amgen Inc
|
3,675 | $1,330,791 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,055 | $1,017,668 | |
| 5 | LLY |
ELI LILLY & Co
|
641 | $768,834 | |
| 6 | NVO |
Novo Nordisk A S
|
11,256 | $539,612 | |
| 7 | PFE |
Pfizer Inc
This page
|
18,621 | $448,393 | |
| 8 | NVS |
Novartis AG
|
1,774 | $278,021 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $448,393 | 18,621 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $522,119 | 18,594 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $457,363 | 18,368 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $467,354 | 18,342 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $443,931 | 18,314 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $463,417 | 18,288 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $490,009 | 18,470 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $552,001 | 19,074 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $539,482 | 19,281 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $534,381 | 19,257 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $563,996 | 19,590 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $649,070 | 19,568 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $714,122 | 19,469 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $793,641 | 19,452 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $985,652 | 19,236 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $841,242 | 19,224 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $1,007,180 | 19,210 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $993,932 | 19,199 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $1,132,933 | 19,186 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $864,802 | 20,107 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $833,129 | 21,275 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $21,261 | 770,300 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $1,561,774 | 42,428 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $1,530,021 | 41,690 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $1,359,536 | 41,576 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $1,351,718 | 41,413 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||